⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Monopar Therapeutics Inc. Common Stock

$69.37
-3.44 (-4.72%)

Volume:

56.493K ($3.92M)

Market Capitalization:

$465.62M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Monopar Therapeutics Market Segments

Regular Trading Hours

-3.08(-4.25%)
Open$72.45
Close$69.37
Low$67.56
Low Change-4.90 (-6.76%)
High$73.28
High Change+0.83 (+1.14%)
Range$5.72
Volume56.493K
Dollar Volume$3.92M

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$72.81
Close$72.81
Low$72.81
Low Change0.00 (0.00%)
High$72.81
High Change+0.00 (+0.00%)
Range$0.00
Volume8.496K
Dollar Volume$618.59K

Regular Trading Hours Yesterday

+2.68(+3.82%)
Open$70.13
Close$72.81
Low$70.00
Low Change-0.13 (-0.19%)
High$74.02
High Change+3.89 (+5.55%)
Range$4.02
Volume165.533K
Dollar Volume$12.05M

Premarket Yesterday

+0.19(+0.27%)
Open$70.30
Close$70.49
Low$69.79
Low Change-0.51 (-0.73%)
High$70.61
High Change+0.31 (+0.44%)
Range$0.82
Volume809
Dollar Volume$57.03K

Monopar Therapeutics News

There is no current news for this stock at the moment.

Monopar Therapeutics Top Trades

Monopar Therapeutics's top trade so far today returned +2.69%, while the top short trade returned -6.76%.

Monopar Therapeutics Moving Averages

5 Day Moving Average (SMA5)$70.28
10 Day Moving Average (SMA10)$71.02
20 Day Moving Average (SMA20)$72.72
50 Day Moving Average (SMA50)$88.67
100 Day Moving Average (SMA100)$95.72
200 Day Moving Average (SMA200)$77.23

Monopar Therapeutics Statistics

Average Volume (30 Days)155.45K
P/E Ratio (Current)-29.68
EPS (Current)-$2.66
Dividend Yield0.00%
Free Cash Flow-$12.18M
Cash Ratio13.14
Current Ratio33.56
Quick Ratio33.56
Debt to Equity0.00
Enterprise Value$477.24M
EV to EBITDA-21.58
EV to Sales—
Price to Book4.05
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.13%
Return on Equity-0.14%

Monopar Therapeutics Stock Splits

There has been 1 stock split for Monopar Therapeutics (MNPR). The reverse stock split occured on August 13, 2024 and reduced the outstanding shares at a ratio of 5:1.

DateTypeRatio
Aug 13, 2024Reverse5:1

Monopar Therapeutics Dividends

There have been no dividends for Monopar Therapeutics (MNPR).